LAMEDITECH Co., Ltd.
🇰🇷XKOS.462510South KoreaHealthcare
Price₩2,720.00+80.00 (+3.03%)
Latest anomalies
Neutral 0 detected in the last 120 days
- High: 5
- Medium: 0
- Low: 0
Capital expenditure to revenue: a sudden drop below its trailing quarter average
Cash conversion cycle: a sudden spike above its trailing quarter average
Days inventory outstanding: a sudden spike above its trailing quarter average
Net profit margin: a sudden drop below its trailing quarter average
Operating cycle: a sudden spike above its trailing quarter average
Free with a Finzer account.
Profile
- Healthcare
- Medical Devices
- South Korea
Identity
- Exchange
- KOSDAQ . XKOS
- Type
- Stock
- ISIN
- Not reported
- CUSIP
- Not reported
Company
- Employees
- 0
- Headquarters
- Seoul, South Korea
- Website
- https://lameditech.com
Market
- Shares outstanding
- 8.8M
- Market cap
- ₩23.86B
Highlights
- Market cap
- ₩23.86B
- EPS LTM
- Not reported
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- Not reported
- Net income
- Not reported
- Gross margin
- Not reported
- Free cash flow
- Not reported
Latest news
News is not sourced for this exchange.
Business summary
LAMEDITECH Co., Ltd. is a company in the healthcare sector, listed on KOSDAQ (South Korea) under the ticker 462510. Its market capitalisation is ₩23.86B, from 8.8M shares outstanding, as of . Across the 240 trading sessions to the shares traded between ₩2,290.00 and ₩9,300.00, and the last close of ₩2,720.00 sits 6% of the way up that range. The company is headquartered in Seoul, South Korea.
Lameditech Co., Ltd. develops, manufactures, and sells laser blood samplers and medical devices in South Korea. It offers laser lancing devices under the HandyRay-Lite and HandyRay names; HandyRay-Pro, a professional laser blood collection device for hospitals and medical institutions; CAREVEAM, a device designed for the treatment of various skin diseases with its 308nm excimer light system; and Ray-Vet, a UVB light irradiation therapy system designed to treat inflammatory skin diseases and various auto-immune diseases in pets and animals. The company was founded in 2012 and is headquartered in Seoul, South Korea.